- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Major histocompatibility complex class II DR beta 1 (HLA-DRB1) is a transmembrane glycoprotein encoded by the HLA-DRB1 gene that forms the beta chain of the HLA-DR antigen receptor responsible for presenting processed peptide antigens to CD4-positive helper T lymphocytes. HLA-DRB1 Antibody Clone Bra30 recognizes the HLA-DR beta chain and has been widely referenced in the literature as Clone Bra30, a mouse monoclonal antibody commonly used to study MHC class II antigen presentation and immune cell activation. The HLA-DR receptor is a heterodimeric complex composed of an alpha chain encoded by HLA-DRA paired with a polymorphic beta chain encoded by HLA-DRB genes, most prominently HLA-DRB1. Together these chains form a peptide-binding receptor that displays extracellularly derived antigens on the cell surface for recognition by CD4-positive T lymphocytes. This antigen presentation pathway is central to adaptive immune responses and immune regulation.
Expression of HLA-DR molecules is characteristic of professional antigen-presenting cells including B lymphocytes, macrophages, dendritic cells, and activated monocytes. Because of this expression pattern, HLA-DRB1 antibodies are widely used in immunology research to identify antigen-presenting immune cell populations and to evaluate immune activation states within tissues and cultured cells. Detection of HLA-DR beta chain expression is particularly useful in studies examining lymphoid tissues, immune cell differentiation, and tumor-associated immune infiltration. Clone Bra30 has been reported in peer-reviewed publications investigating the distribution and function of MHC class II molecules on immune cells. In these studies, HLA-DRB1 Antibody Clone Bra30 has been used to examine antigen-presenting cell populations and the regulation of immune responses mediated through the HLA-DR pathway.
The HLA-DRB1 gene exhibits extensive allelic diversity across human populations, contributing to variability in peptide binding specificity and immune responsiveness. Certain HLA-DRB1 variants have been associated with susceptibility to autoimmune diseases and immune-mediated disorders including rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. Because of these biological roles, antibodies such as HLA-DRB1 Antibody Clone Bra30 are valuable tools for investigating antigen presentation pathways, immune activation, and immune regulation in immunology and disease-related research.
Optimal dilution of the HLA-DRB1 Antibody Clone Bra30 should be determined by the researcher.
Human REH cells (a non-T, non-B leukemia cell line) were used as the immunogen for the HLA-DRB1 antibody.
Store the HLA-DRB1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
HLA-DR beta antibody, HLA-DRB1 antibody, MHC class II DR beta antibody, HLA class II histocompatibility antigen DR beta antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.